Artois, France

André Tartar

This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Institut Pasteur De Lille, National Institute of Health and Medical Research. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: André Tartar. Retrieved from https://idiyas.com/inventor/andré-tartar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: André Tartar: Innovator in Immunology

Introduction

André Tartar is a notable inventor based in Artois, France. He has made significant contributions to the field of immunology through his innovative research and patents. His work focuses on developing new methods to induce immune responses, which can have profound implications for medicine and vaccine development.

Latest Patents

André Tartar holds a patent for "Mixed lipopeptide micelles for inducing an immune response." This invention involves mixed micelles or micro-aggregates that contain at least a first lipopeptide with a CTL epitope and a first lipid motif, along with a second lipopeptide that includes an auxiliary T epitope and a lipid motif. The micelles can be utilized as medicines and vaccines, showcasing Tartar's commitment to advancing healthcare.

Career Highlights

Throughout his career, Tartar has worked with prestigious institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

André Tartar has collaborated with notable colleagues, including Hélène Gras-Masse and Marc Bossus. These partnerships have enriched his research and expanded the impact of his innovations.

Conclusion

André Tartar's work in developing mixed lipopeptide micelles represents a significant advancement in immunology. His contributions to medicine and vaccine development highlight the importance of innovation in addressing health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…